What is AIFC's accrued litigation?

AIFC (AIFC) reported accrued litigation of $660K in Q1 2026.

How has AIFC's accrued litigation changed year-over-year?

AIFC's accrued litigation increased by 1220.0% year-over-year, from $50K to $660K.

What is the long-term trend for AIFC's accrued litigation?

Over 3 years (2022 to 2025), AIFC's accrued litigation has grown at a 9.0% compound annual growth rate (CAGR), from $510K to $660K.

AIFC AIFC Accrued litigation

Accrued litigation at other companies

Indivior Pharmaceuticals, Inc. INDV

——

Other financials

Income statement

See full

Revenue$4.7M-2.8%

Gross profit$3.6M+85.6%

Operating income-$2.7M-41.0%

Net income-$271.5M-11,250%

EPS (diluted)-$2.14-1,327%

Balance sheet

See full

Cash & equivalents$10.5M-2.7%

Total debt$107.0K-99.4%

Total equity$889.7M+3,976%

Total assets$959.7M+1,130%

Cash flow

See full

Operating cash flow-$12.3M-764%

CapEx$2.8K—

Free cash flow-$1.8M—

Valuation

See full

Market cap$0+43,568%

Profitability

See full

Gross margin46.5%+1.2pp

Operating margin-99.7%-717pp

Net margin-2,552.7%-2,601pp

FCF margin-29.7%—

Returns & leverage

See full

Return on equity-134.6%-791pp

Debt / equity0×-0.5×

Current ratio0.8×0.0×

Where this comes from

Reported directly by AIFC in its filing.

Tagged under the XBRL concept us-gaap:LitigationReserveCurrent.

The official record: AIFC’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about AIFC's accrued litigation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AIFC's accrued litigation?: AIFC (AIFC) reported accrued litigation of $660K in Q1 2026.
How has AIFC's accrued litigation changed year-over-year?: AIFC's accrued litigation increased by 1220.0% year-over-year, from $50K to $660K.
What is the long-term trend for AIFC's accrued litigation?: Over 3 years (2022 to 2025), AIFC's accrued litigation has grown at a 9.0% compound annual growth rate (CAGR), from $510K to $660K.